Table 4.
Molecular interactions of the α-glucosidase (3A4A) active site with luteolin, luteolin 5-O-β-d-glucopyranoside and luteolin 7-O-β-d-glucopyranoside as well as reported inhibitors.
| Compounds | Docking Score (kcal/mol) | No. of H-Bond | H-Bond Interacting Residues | Hydrophobic Interacting Residues |
|---|---|---|---|---|
| Luteolin (Allosteric) | −7.25 | 5 | Glu271, Ile272, Ser298, Thr274 | Gly269, Arg270, Glu296, Asn259, Ile262, Val266, Arg263 |
| Luteolin 5-O-β-d-glucopyranoside (Catalytic) | −7.22 | 7 | His112, Asp215, Gln182, Tyr158, Glu411, Asp307, Gln353 | Asp69, Tyr72, Phe159, Arg315, His280, Asp352, Phe303, Arg442, Val109, Phe178 |
| Luteolin 5-O-β-d-glucopyranoside (Allosteric) | −6.98 | 6 | Thr290, Ser298, Ile272, Arg270, His295 | Asp341, Cys342, Trp15, Asn259, Ile262, Arg263, Glu271, Thr274, Leu297, Ala292 |
| Luteolin 7-O-β-d-glucopyranoside (Catalytic) | −7.21 | 6 | Asp69, Arg442, Pro312, Asp242, His280 | Phe159, Glu277, Asp352, Phe314, Phe303, Arg315, Leu313, Tyr158, Gln279, Val216, Asp215, Phe178 |
| Acarbose a (Catalytic inhibitor) |
−8.59 | 17 | Gln182, Asp69, Asp215, Arg213, Glu277, Asp352, Arg442, Asp307, His280, Asp242, Ser240, Tyr158 | Lys156, Arg315, Gln279, Phe178, Phe303, Gln353, Tyr72, Val216, His351, Glu411 |
| BIP b (Allosteric inhibitor) |
−6.89 | 2 | Glu296, His295 | Asp341, Cys342, Ala292, Arg294, Leu297, Ser291, Asn259, Thr290, Ser298, Trp15, Lys16, Trp343 |
a Reported competitive inhibitor. b Reported allosteric inhibitor.